Trials / Completed
CompletedNCT02481726
68Ga-AlfatideII for the Differential Diagnosis of of Lung Cancer and Lung Tuberculosis by PET/CT
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Xijing Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Comparison of 68Ga-AlfatideII and 18F-FDG in differential diagnosis effectiveness towards the solitary pulmonary nodules of lung cancer or tuberculosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | 68Ga-labeled peptides of dimer RGD (Alfatide II) and 18F-FDG |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2014-10-01
- First posted
- 2015-06-25
- Last updated
- 2015-06-25
Source: ClinicalTrials.gov record NCT02481726. Inclusion in this directory is not an endorsement.